|
1) Ohmichi M, Kanda Y, Hisamoto K, et al. Rapid changes of flow-mediated dilatation after surgical menopause. Maturitas. 2003; 44: 125-31
|
|
|
|
2) Wakatsuki A, Okatani Y, Ikenoue N, et al. Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen. Circulation. 2001; 104: 1773-8
|
|
|
|
|
|
3) Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288: 321-33
|
|
|
|
|
|
4) Ross A. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993; 362: 801-9
|
|
|
|
|
|
5) Dai-Do D, Espinosa E, Liu G, et al. 17β-estradiol inhibits proliferation and migration of human vascular smooth muscle cells: similar effects in cells from postmenopausal females and in males. Cardiovasc Res. 1996; 32: 980-85
|
|
|
|
|
|
6) Kolodgie FD, Jacob A, Wilson PS, et al. Estradiol attenuates directed migration of vascular smooth muscle cells in vitro. Am J Pathol. 1996; 48: 969-76
|
|
|
|
|
|
7) Suzuki A, Mizuno K, Ino Y, et al. Effect of 17β-estradiol and progesterone on growth-factor-induced proliferation and migration in human female aortic smooth muscle cells in vitro. Cardiovasc Res. 1996; 32: 516-23
|
|
|
|
|
|
8) Somjen D, Kohen F, Jaffe A, et al. Effects of gonadal steroids and their antagonists on DNA synthesis in human vascular cells. Hypertension. 1998; 32: 39-45
|
|
|
|
|
|
9) Graves LM, Bornfeldt KE, Sidhu JS, et al. Platelet-derived growth factor stimulates protein kinase A through a mitogen-activated protein kinase-dependent pathway in human arterial smooth muscle cells. J Biol Chem. 1996; 271: 505-11
|
|
|
|
|
|
10) Dubey RK, Gillespie DG, Imthurn B, et al. Phytoestrogens inhibit growth and MAP kinase activity in human aortic smooth muscle cells. Hypertension. 1999; 33: 177-82
|
|
|
|
|
|
11) Lavoie JN, L'Allemain G, Brunet A, et al. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem. 1996; 271: 20608-16
|
|
|
|
|
|
12) Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995; 81: 323-30
|
|
|
|
|
|
13) La Thangue NB. E2F and the molecular mecha-nisms of early cell-cycle control. Biochem Soc Trans. 1996; 24: 54-9
|
|
|
|
|
|
14) Marra DE, Simoncini T, Liao JK. Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21waf1 and p27kip1. Circulation. 2000; 102: 2124-30
|
|
|
|
|
|
15) Wakino S, Kintscher U, Kim S, et al. Retinoids inhibits proliferation of human coronary smooth muscle cells by modulating cell cycle regulators. Arterioscler Thromb Vasc Biol. 2001; 21: 746-51
|
|
|
|
|
|
16) Yang Z, Kozai T, von der Loo B, et al. HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins. J Am Coll Cardiol. 2000; 36: 1691-7
|
|
|
|
|
|
17) Kintscher U, Wakino S, Kim S, et al. Doxazosin inhibits retinoblastoma protein phosphorylation and G1→S transition in human coronary smooth muscle cells. Arterioscler Thromb Vasc Biol. 2000; 20: 1216-24
|
|
|
|
|
|
18) Takahashi K, Ohmichi M, Yoshida M, et al. Both estrogen and raloxifene cause G1 arrest of vascular smooth muscle cells. J Endocrinol. 2003; 178: 319-29
|
|
|
|
|
|
19) Mori-Abe A, Tsutsumi S, Takahashi K, et al. Estrogen and raloxifene induce apoptosis by activating p38 mitrogen-activated protein kinase cascade in synthetic vascular smooth muscle cells. J Endrocrinol. 2003; 178: 417-26
|
|
|
|
|
|
20) Rosselli M, Imthurn B, Keller PJ, et al. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol and norethisterone acetate. A two-year follow-up study. Hypertension. 1995; 25: 848-53
|
|
|
|
|
|
21) Hisamoto K, Ohmichi M, Kurachi H, et al. Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem. 2001; 276: 3459-67
|
|
|
|
|
|
22) Pignoli P, Tremoli E, Poli A, et al. Intimal plus medial thickness of the arterial wall: a direct measurementwith ultrasound imaging. Circulation. 1986; 74: 1399-406
|
|
|
|
|
|
23) Hodis HN, Mack WJ, Lobo RA, et al. Estrogen in the prevention of atherosclerosis; a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2001; 135: 939-53
|
|
|
|
|
|
24) Takahashi K, Tanaka E, Murakami M, et al. Long-term hormone replacement therapy delays the age related progression of carotid intima-media thickness in healthy postmenopausal women. Maturitas. 2004; 49: 170-7
|
|
|
|
|
|
25) Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior？ The 1995 Ancel Keys Lecture. Circulation. 1997; 95: 252-64
|
|
|
|
|
|
26) Stampfer MJ, Colditz GA, Willett WC, et al. Ten-year follow-up from the nurses' health study. N Engl J Med. 1991; 325: 756-62
|
|
|
|
|
|
27) Cui R, Iso H, Toyoshima H, et al. Relationships of age at menarche and menopause, and reproductive year with mortality from cardio-vascular disease in Japanese postmenopausal women: the JACC study. J Epidemiol. 2006; 16: 177-84
|
|
|
|
|
28) Grodstein F, Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis. 1995; 38: 199-210
|
|
|
|
|
|
29) Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999; 340: 1801-11
|
|
|
|
|
|
30) Mikkola TS, Clarkson TB. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res. 2002; 53: 605-19
|
|
|
|
|
|
31) Matthews KA, Meilahn E, Kuller LH, et al. Menopause and risk factors for coronary heart disease. N Engl J Med. 1989; 321: 641-6
|
|
|
|
|
|
32) Chen SJ, Li H, Durand J, et al. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation. 1996; 93: 577-84
|
|
|
|
|
|
33) Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998; 280: 605-13
|
|
|
|
|
|
34) Grady D, Herrington D, Bittner V, et al; HERS Research Group. Cardiovascular disease out-comes during 6. 8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA. 2002; 288: 49-57
|
|
|
|
|
|
35) Viscoli CM, Brass LM, Kernan WN, et al. A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med. 2001; 345: 1243-9
|
|
|
|
|
|
36) Hodis HN, Mack WJ, Lobo RA, et al. Estrogen in the Prevention of Atherosclerosis Trial Research Group. Estrogen in the prevention of athero-sclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2001; 135: 939-53
|
|
|
|
|
|
37) Hsia J, Langer RD, Manson JE, et al. Women's Health Initiative Investigators. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med. 2006; 166: 357-65
|
|
|
|
|
|
38) Grodstein F, Manson JE, Stampfer MJ. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health (Larchmt). 2006; 15: 35-44
|
|
|
|
|
|
39) Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007; 297: 1465-77
|
|
|
|
|
|
40) Manson JE, Allison MA, Rossouw JE, et al. WHI and WHI-CACS Investigators. Estrogen therapy and coronary-artery calcification. N Engl J Med. 2007; 356: 2591-602
|
|
|
|
|
|
41) Bray PF, Larson JC, Lacroix AZ, et al. Women's Health Initiative Investigators. Usefulness of baseline lipids and C-reactive protein in women receiving menopausal hormone therapy as predictors of treatment-related coronary events. Am J Cardiol. 2008; 101: 1599-1605
|
|
|
|
|
|
42) Umetani M, Domoto H, Gormley AK, et al. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estro-gen. Nat Med. 2007; 13: 1185-92
|
|
|
|
|
|
43) Harman SM, Brinton EA, Cedars M, et al. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric. 2005; 8: 3-12
|
|
|
|
|